DK1646649T3 - Macc1-polypeptid og dets anvendelse til tumordiagnostik og tumorterapi. - Google Patents
Macc1-polypeptid og dets anvendelse til tumordiagnostik og tumorterapi.Info
- Publication number
- DK1646649T3 DK1646649T3 DK04741141.8T DK04741141T DK1646649T3 DK 1646649 T3 DK1646649 T3 DK 1646649T3 DK 04741141 T DK04741141 T DK 04741141T DK 1646649 T3 DK1646649 T3 DK 1646649T3
- Authority
- DK
- Denmark
- Prior art keywords
- tumor
- macc1
- polypeptide
- diagnostics
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10332854A DE10332854A1 (de) | 2003-07-18 | 2003-07-18 | Verwendung des neu-identifizierten humanen Gens 7a5/Prognostin für Tumordiagnostik und Tumortherapie |
| PCT/EP2004/008053 WO2005010042A1 (de) | 2003-07-18 | 2004-07-19 | 7a5/prognostin und dessen verwendung für die tumordiagnostik und tumortherapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1646649T3 true DK1646649T3 (da) | 2013-06-03 |
Family
ID=34071785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04741141.8T DK1646649T3 (da) | 2003-07-18 | 2004-07-19 | Macc1-polypeptid og dets anvendelse til tumordiagnostik og tumorterapi. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7851168B2 (da) |
| EP (1) | EP1646649B1 (da) |
| JP (1) | JP4742036B2 (da) |
| AU (1) | AU2004259281B2 (da) |
| CA (1) | CA2526240C (da) |
| DE (1) | DE10332854A1 (da) |
| DK (1) | DK1646649T3 (da) |
| ES (1) | ES2409338T3 (da) |
| WO (1) | WO2005010042A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201301571D0 (en) * | 2012-11-27 | 2013-03-13 | Fundanci N Pedro Barri De La Maza | Product and use |
| JP2015057974A (ja) * | 2013-09-18 | 2015-03-30 | 学校法人順天堂 | 患者原発性大腸癌の個別化転移モデルマウスの作製方法 |
| KR102682748B1 (ko) * | 2016-09-23 | 2024-07-15 | (주)아모레퍼시픽 | Sh3bp4 억제 물질을 포함하는 피부 미백용 조성물 및 sh3bp4 억제 물질의 스크리닝 방법 |
| WO2018091419A1 (en) | 2016-11-15 | 2018-05-24 | Ventana Medical Systems, Inc. | Compositions and methods for prognosing and treating colorectal cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE174600T1 (de) | 1993-10-27 | 1999-01-15 | Ribozyme Pharm Inc | 2'-amido-und 2'-peptido-modifizierte oligonukleotide |
| GB9602326D0 (en) | 1996-02-06 | 1996-04-03 | Cruachem Ltd | Compounds |
| WO1998037240A1 (en) | 1997-02-24 | 1998-08-27 | Tm Technologies, Inc. | Anti-sense oligonucleotide pharmacological agents |
| AU3087801A (en) * | 2000-02-04 | 2001-08-14 | Molecular Dynamics Inc | Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells |
| AU2001294943A1 (en) * | 2000-10-02 | 2002-04-15 | Bayer Corporation | Nucleic acid sequences differentially expressed in cancer tissue |
| AU2002255478A1 (en) * | 2001-01-10 | 2002-09-12 | Pe Corporation (Ny) | Kits, such as nucleic acid arrays, comprising a majority of human exons or transcripts, for detecting expression and other uses thereof |
-
2003
- 2003-07-18 DE DE10332854A patent/DE10332854A1/de not_active Ceased
-
2004
- 2004-07-19 DK DK04741141.8T patent/DK1646649T3/da active
- 2004-07-19 AU AU2004259281A patent/AU2004259281B2/en not_active Ceased
- 2004-07-19 CA CA2526240A patent/CA2526240C/en not_active Expired - Fee Related
- 2004-07-19 WO PCT/EP2004/008053 patent/WO2005010042A1/de not_active Ceased
- 2004-07-19 JP JP2006519895A patent/JP4742036B2/ja not_active Expired - Fee Related
- 2004-07-19 ES ES04741141T patent/ES2409338T3/es not_active Expired - Lifetime
- 2004-07-19 EP EP04741141A patent/EP1646649B1/de not_active Expired - Lifetime
- 2004-07-19 US US10/564,823 patent/US7851168B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7851168B2 (en) | 2010-12-14 |
| DE10332854A1 (de) | 2005-02-17 |
| EP1646649B1 (de) | 2013-02-27 |
| WO2005010042A1 (de) | 2005-02-03 |
| US20060228370A1 (en) | 2006-10-12 |
| AU2004259281A1 (en) | 2005-02-03 |
| EP1646649A1 (de) | 2006-04-19 |
| JP2007537701A (ja) | 2007-12-27 |
| ES2409338T3 (es) | 2013-06-26 |
| CA2526240C (en) | 2014-09-16 |
| CA2526240A1 (en) | 2005-02-03 |
| JP4742036B2 (ja) | 2011-08-10 |
| AU2004259281B2 (en) | 2011-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1641822T3 (da) | Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf. | |
| NO20053817D0 (no) | Preparater og fremgangsmater for antiviral kombinasjonsterapi. | |
| DK1687049T3 (da) | Sprøjter, sprøjtegrænseflader og sprøjtestempler til anvendelse med medicinske injektorer | |
| NO20053974D0 (no) | Tienopyrimidinforbindelser og anvendelse derav. | |
| DK1287140T3 (da) | Antistofmolekyler, der har specificitet overfor human tumornekrosefaktor-alfa og anvendelse deraf | |
| IS8434A (is) | Verndandi vírnet, verndandi formgerð búin til meðnetinu og notkunin á verndandi vírnetinu við að búa til verndandi formgerð | |
| NO20053126D0 (no) | Kontrollsystem for medisinsk behandling. | |
| IS7684A (is) | Ný efnasambönd, blöndur og aðferðir til að meðhöndla bólgusjúkdóma og -ástand | |
| EP1446129A4 (en) | POLYNUCLEOTIDE THERAPY | |
| IS8071A (is) | Aðferð við meðhöndlun á hnútahersli, fitudreyra og tengdum ástands tegundum og lyfjafræðilegum samsetningum | |
| DK1511734T3 (da) | Forbindelser, præparater og fremgangsmåder | |
| DE602004028934D1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
| AP2006003537A0 (en) | Use of polypeptides of the cupredoxin family in cancer therapy. | |
| IS7137A (is) | Samsett meðferð til meðhöndlunar á krabbameini | |
| ITMI20031145A1 (it) | Dispositivo e procedimento di cottura. | |
| NO20040918L (no) | Fremgangsmate og anordning for lagdelt modulasjon. | |
| NO20026128L (no) | Gelformet drivstoff, fremgangsmåte for dets fremstilling og dets anvendelse | |
| NO20051983D0 (no) | 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav. | |
| IS7798A (is) | Efnasambönd, lyfjablöndur og aðferðir | |
| ZA200500882B (en) | Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis of treatment or liver disorders and epithelial cancer | |
| NO20055708D0 (no) | Syntetisk gen som koder for humant karsinembryonalt antigen og anvendelser derav | |
| DK1646649T3 (da) | Macc1-polypeptid og dets anvendelse til tumordiagnostik og tumorterapi. | |
| DK1660532T3 (da) | Fusionspolypeptider, og anvendelse deraf i antivaskulær tumorterapi | |
| NO20054049D0 (no) | Fremgangsmate for diagnose og behandling. | |
| DK1639107T3 (da) | Forbedrede proteaser og fremgangsmåder til fremstilling deraf |